MedTrace Logo

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

NCT06852950 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-03-05

No results posted yet for this study

Summary

This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting to the ambulatory setting.

Conditions

  • Type 2 Diabetes Mellitus (T2DM)
  • Type 1 Diabetes Mellitus (T1DM)
  • Hyperglycemia

Interventions

DEVICE

Libre 3 Plus Continuous Glucose Monitor

Subjects in this arm will start using the Libre 3 Plus continuous glucose monitor.

DEVICE

Dexcom G7 Continuous Glucose Monitor

Subjects in this arm will start using the Dexcom G7 continuous glucose monitor.

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-09
Primary Completion
2027-01-31
Completion
2027-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06852950 on ClinicalTrials.gov